SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016514
Filing Date
2023-05-12
Accepted
2023-05-12 09:20:25
Documents
64
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 686430
2 ex31-1.htm EX-31.1 20100
3 ex31-2.htm EX-31.2 19110
4 ex32-1.htm EX-32.1 8494
  Complete submission text file 0001493152-23-016514.txt   3877131

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE pulm-20230331.xsd EX-101.SCH 35980
6 XBRL CALCULATION FILE pulm-20230331_cal.xml EX-101.CAL 48624
7 XBRL DEFINITION FILE pulm-20230331_def.xml EX-101.DEF 123920
8 XBRL LABEL FILE pulm-20230331_lab.xml EX-101.LAB 290499
9 XBRL PRESENTATION FILE pulm-20230331_pre.xml EX-101.PRE 214515
58 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 483426
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36199 | Film No.: 23913533
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences